pharmaceutical investing RYBREVANT FASPRO plus LAZCLUZE® with prophylactic strategies shows low rates of treatment-related events at WCLC 2026
pharmaceutical investing Johnson & Johnson's RYBREVANT® plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer
pharmaceutical investing Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
pharmaceutical investing Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026
pharmaceutical investing Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
pharmaceutical investing FDA approves IMAAVY® as first-ever treatment for warm autoimmune hemolytic anemia , representing a landmark advancement for patients
pharmaceutical investing Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
pharmaceutical investing Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference
pharmaceutical investing Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
pharmaceutical investing Johnson & Johnson's RYBREVANT FASPRO receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer
pharmaceutical investing Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
pharmaceutical investing Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
pharmaceutical investing Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
GoldInxs Advances Fishpot Toward Maiden Drill Program with New 3D IP Survey, Magnetic and Virtual DRILL Results
JAGUAR URANIUM REPORTS RARE EARTH OXIDES ASSOCIATED WITH URANIUM-PHOSPHATE-VANADIUM MINERALIZATION AT THE BERLIN ASSET IN COLOMBIA
Spartan Metals Receives BLM Approval for Seven Additional Drill Sites at its Tungstonia Claims, Nevada
